☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Combine
MannKind Enter into an Agreement with One Drop to Combine Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platfo...
August 6, 2019
Editas Medicine Signs a Research and Cross-Licensing Agreement with BlueRock Therapeutics for their Technologies
April 4, 2019
Organogenesis Reverse Merges with Avista Healthcare Public Acquisition Corp. (AHPAC)
August 20, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
